Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

182.50
Delayed Data
As of Sep 01
 -7.26 / -3.83%
Today’s Change
128.50
Today|||52-Week Range
314.88
+16.99%
Year-to-Date

Stock Price Forecast

The 15 analysts offering 12-month price forecasts for Intercept Pharmaceuticals Inc have a median target of 410.00, with a high estimate of 500.00 and a low estimate of 165.00. The median estimate represents a +124.66% increase from the last price of 182.50.

Analyst Recommendations

The current consensus among 15 polled investment analysts is to Buy stock in Intercept Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$2.77
Sales
$412.1K
Reporting Date
Nov 12

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -39.21%
 
 
 
 
 
 
Growthannually 23.98%
 
 
 
 
 

Sales

Growthquarterly -7.39%
 
 
 
 
 
 
Growthannually 63.04%
 
 
 
 
 
Key to the earnings and sales forecast charts.